The medical devices industry continues to be a hotbed of innovation, with activity driven by increased need for homecare, preventative treatments, early diagnosis, reducing patient recovery times and improving outcomes, as well as a growing importance in technologies such as machine learning, augmented reality, 5G and digitalization. In the last three years alone, there have been over 450,000 patents filed and granted in the medical devices industry. , according to GlobalData’s report on Innovation in Medical Devices: Syringe pump controls. Buy the report here.
However, not all innovations are equal and nor do they follow a constant upward trend. Instead, their evolution takes the form of an S-shaped curve that reflects their typical lifecycle from early emergence to accelerating adoption, before finally stabilising and reaching maturity.
Identifying where a particular innovation is on this journey, especially those that are in the emerging and accelerating stages, is essential for understanding their current level of adoption and the likely future trajectory and impact they will have.
150+ innovations will shape the medical devices industry
According to GlobalData’s Technology Foresights, which plots the S-curve for the medical devices industry using innovation intensity models built on over 550,000 patents, there are 150+ innovation areas that will shape the future of the industry.
Within the emerging innovation stage, neurostimulation therapy, smart physiotherapy devices, and real-time IR thermographic imaging are disruptive technologies that are in the early stages of application and should be tracked closely. Precision radiotherapy, electric atomisers, and bio-active prosthesis coating are some of the accelerating innovation areas, where adoption has been steadily increasing. Among maturing innovation areas are bioresorbable stent coating and cryogenic tissue treatment, which are now well established in the industry.
Innovation S-curve for the medical devices industry
Syringe pump controls is a key innovation area in the medical devices industry
Syringe pumps are battery-powered devices that precisely control the fluid movement from a syringe at a set rate into the patient’s body by mechanically inserting or retracting the plunger. They are preferred when oral routes cannot be used to deliver medications.
GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies. According to GlobalData, there are 70+ companies, spanning technology vendors, established medical devices companies, and up-and-coming start-ups engaged in the development and application of syringe pump controls.
Key players in syringe pump controls – a disruptive innovation in the medical devices industry
‘Application diversity’ measures the number of different applications identified for each relevant patent and broadly splits companies into either ‘niche’ or ‘diversified’ innovators.
‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.
Patent volumes related to syringe pump controls
Source: GlobalData Patent Analytics
Becton Dickinson is one of the leading patent filers in the field of syringe pump controls. Some other key patent filers in the field include Johnson & Johnson and Teleflex.
In terms of application diversity, Sewon Cellontech leads the pack, followed by Kimberly-Clark and Ferrosan Medical Devices. By means of geographic reach, Kimberly-Clark holds the top position, followed by Waypoint Capital Holdings (Jersey) and Massachusetts General Hospital in second and third spots, respectively.
Syringe pumps are distinguished by their responsiveness and stability. They are used to minimize errors during fluid delivery and provide flexibility based on the application. Advancements in technology would allow for cost-effective syringe pumps with variable flow rates. This would allow automated real-time control of fluid delivery into the patient’s body as per metabolic requirements.
To further understand the key themes and technologies disrupting the medical devices industry, access GlobalData’s latest thematic research report on Medical Devices.